BridgeBio Pharma Files 8-K on Financials
Ticker: BBIO · Form: 8-K · Filed: Feb 20, 2025 · CIK: 1743881
| Field | Detail |
|---|---|
| Company | Bridgebio Pharma, Inc. (BBIO) |
| Form Type | 8-K |
| Filed Date | Feb 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, corporate-update
Related Tickers: BBIO
TL;DR
BridgeBio Pharma dropped an 8-K on Feb 20th covering financials. Check it out.
AI Summary
BridgeBio Pharma, Inc. filed an 8-K on February 20, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 3160 Porter Dr., Suite 250, Palo Alto, CA 94304. The company was formerly known as BridgeBio Pharma LLC until June 18, 2018.
Why It Matters
This 8-K filing provides an update on BridgeBio Pharma's financial status and operational results, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- BridgeBio Pharma, Inc. (company) — Registrant
- February 20, 2025 (date) — Date of Report
- 3160 Porter Dr., Suite 250, Palo Alto, CA 94304 (address) — Principal Executive Offices
- BridgeBio Pharma LLC (company) — Former Company Name
- 20180618 (date) — Date of Name Change
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on BridgeBio Pharma, Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
When was this 8-K report filed?
This 8-K report was filed on February 20, 2025.
Where are BridgeBio Pharma, Inc.'s principal executive offices located?
BridgeBio Pharma, Inc.'s principal executive offices are located at 3160 Porter Dr., Suite 250, Palo Alto, CA 94304.
What was BridgeBio Pharma, Inc.'s former name?
BridgeBio Pharma, Inc.'s former name was BridgeBio Pharma LLC.
On what date did the company change its name from BridgeBio Pharma LLC?
The company changed its name from BridgeBio Pharma LLC on June 18, 2018.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 20, 2025 regarding BridgeBio Pharma, Inc. (BBIO).